FOMC minutes and UK data on the schedule

By JustForex

Stock markets continue to fall amid hawkish comments from the Federal Reserve indicating the need to tighten monetary policy further and keep rates higher. As the stock market closed Tuesday, the Dow Jones Index (US30) added 0.12%, while the S&P 500 Index (US500) decreased by 0.65%. The NASDAQ Technology Index (US100) fell by 1.10% yesterday.

Federal Reserve Bank of Cleveland President Loretta Mester echoed recent remarks from other Fed officials, calling for the Fed to continue to raise interest rates to put inflation on a steady downward trajectory to 2%. In anticipation of another significant rate hike, Treasury yields rose to 4%.

The president of the World Bank and the managing director of the International Monetary Fund added caution to the market, warning of the growing risk of a global recession and stating that inflation remains an ongoing problem. The International Monetary Fund warned Tuesday that countries that account for a third of global output could face a recession next year.

Markets are now awaiting key US inflation data this week, which is expected to influence the Fed’s plan to raise interest rates. The minutes of the Fed’s September meeting, which will be released today, will also be monitored for more hawkish signals.

Equity markets in Europe were mostly down yesterday. Germany’s DAX (DE30) fell by 0.43%, France’s CAC 40 (FR40) decreased by 0.13%, Spain’s IBEX 35 (ES35) lost 0.78%, Britain’s FTSE 100 (UK100) closed down by 1.06%.

The UK unemployment rate fell to a new low. If markets are calmer ahead of the Bank of England’s November meeting, the Bank of England is likely to opt for a 75 basis point hike. But if market volatility persists and the pound continues to weaken, the Bank will be forced to act more decisively. Whether we get a 75- or 100-basis-point rate hike will depend on whether the government’s fiscal plan succeeds in stabilizing the markets at the end of October. For now, uncertainty in the UK bond market is forcing investors to sell off the pound and move into safe-haven assets such as the dollar index.

The number of Covid cases in China reached its highest level since August, with the spike coming after an increase in domestic travel during the National Golden Week holiday earlier this month. Shanghai and other major Chinese cities, including Shenzhen, stepped up testing as cases of the coronavirus increased, and some local authorities hastily closed schools, entertainment venues, and tourist spots. As a result, oil prices have fallen 3% since the beginning of this week amid falling demand.

Gold has fallen below $1,700 an ounce. Investors are moving into dollars ahead of key US inflation data this week and before FOMC minutes are released today.

Asian markets traded lower yesterday. Japan’s Nikkei 225 (JP225) lost 2.64% over the day, Hong Kong’s Hang Seng (HK50) fell by 2.23%, and Australia’s S&P/ASX 200 (AU200) was down by 0.34%.

China’s Central Bank on Tuesday spoke out against major exchange rate fluctuations, saying it would take steps to stabilize expectations and keep the yuan stable. The People’s Bank of China (PBOC) also said that the yuan does not necessarily need to weaken against the dollar. The Central Bank said it has plenty of policy options, many tools, and “extensive experience in effectively managing market expectations and ensuring exchange rate stability.

Markets are also waiting for China’s inflation and trade data, due out Friday, to get more signals about a potential economic recovery.

The Bank of Korea (BoK) raised interest rates by 50 basis points to 3%, bringing lending rates to the highest level in a decade. The move comes as the country struggles with inflation hitting a 24-year high this year, hitting Asia’s fourth-largest economy hard.

S&P 500 (F) (US500) 3,588.84 −23.55 (−0.65%)

Dow Jones (US30) 29,239.19 +36.31 (+0.12%)

DAX (DE40) 12,220.25 −52.69 (−0.43%)

FTSE 100 (UK100) 6,885.23 −74.08 (−1.06%)

USD Index 113.25 +0.11 (+0.10%)

Important events for today:
  • – UK GDP (m/m) at 09:00 (GMT+3);
  • – UK Industrial Production (m/m) at 09:00 (GMT+3);
  • – UK Manufacturing Production (m/m) at 09:00 (GMT+3);
  • – UK FPC Meeting Minutes (Tentative);
  • – UK FPC Statement (Tentative);
  • – Eurozone Industrial Production (m/m) at 12:00 (GMT+3);
  • – US Producer Price Index (m/m) at 15:30 (GMT+3);
  • – Eurozone ECB President Lagarde Speaks (m/m) at 16:30 (GMT+3);
  • – US FOMC Meeting Minutes at 21:00 (GMT+3).

By JustForex

 

This article reflects a personal opinion and should not be interpreted as an investment advice, and/or offer, and/or a persistent request for carrying out financial transactions, and/or a guarantee, and/or a forecast of future events.

Allstate (ALL) Stock increased by 1.99 percent, trend is bullish – October 11 2022

By InvestMacro.com | #stocks #ALL

The Allstate Corporation End of Day Update: October 11 2022

The The Allstate Corporation (ALL) stock ended the day with an increase just below 2.00 percent and closed the day around the 133.99 price level, according to unofficial data at the New York close.

Allstate, an American insurance company with a market cap of approximately $35 billion currently, opened the day trading at 131.37 with the high of the day being 134.03 and the low of the day at 130.99.

This stock has been on the uptrend and is trading above both the long-term 200-day moving average and the short-term 20-day moving average as well.

Allstate (ALL) Stock increased by 1.99 percent, trend is bullish

The ALL RSI level is Bullish

The Relative Strength Index, an indicator that can indicate overbought (above 70) and oversold levels (below 30), shows that the current RSI is at 62.8 for a Bullish score reading on the daily time-frame.

ALL Price Trends (Closing Price Changes) show a rising stock

The ALL has advanced by 8.21 percent over the past 10 days while seeing an advance by 8.72 over the past 30 days. The 90-day change is 0.57 while the 180-day return and the 365-day return are 12.15 and 9.88, respectively.

ALL Price Trends (Closing Price Changes) show a rising stock

By InvestMacro.com Get our stock market newsletter for stock rankings, news & updates

AGNC Stock Today jumped by 10.41 percent – October 11 2022

By InvestMacro.com | #stocks #AGNC

AGNC Investment Corp. End of Day Update: October 11 2022

The AGNC Investment Corp. (AGNC) stock finished the day with a gain of 10.41 percent and closed the day around the 8.17 price level, according to unofficial data at the New York close.

AGNC, a mortgage REIT or Real Estate Investment Trust, opened the day trading at 7.4 with the high of the day being 8.27 and the low of the day at 7.395.

Today’s jump was a welcome sight for REIT investors as AGNC recently hit its lowest share price since the depths of the pandemic lows in March of 2020.

AGNC currently sports a sky-high dividend over 17 percent at the moment as the Real Estate industry and stocks have been hit hard by rising interest rates.

AGNC Stock Today jumped by 10.41 percent

The AGNC RSI level is Bearish

The Relative Strength Index, an indicator that can indicate overbought (above 70) and oversold levels (below 30), shows that the current RSI score is at 32.1 for a Bearish reading on the daily time-frame.

AGNC Price Trends (Closing Price Changes) are all negative

The AGNC is lower by -10.02 percent over the past 10 days while seeing a fall of -32.98 over the past 30 days. The 90-day change is -30.93 while the 180-day return and the 365-day return are -40.08 and -48.19, respectively.

AGNC Stock Today jumped by 10.41 percent

By InvestMacro.com Get our stock market newsletter for stock rankings, news & updates

PFE Stock today rose by 1.64 percent after close to 52-week low – October 11 2022

By InvestMacro.com | #stocks #PFE

Pfizer Inc. End of Day Update: October 11 2022

The Pfizer Inc. (PFE) stock finished the day with a rise of 1.64 percent and closed the day around the 42.375 price level, according to unofficial data at the New York close.

PFE, the American pharmaceutical company, opened the day trading at 41.69 with the high of the day being 42.39 and the low of the day at 41.445. The PFE stock, despite an increase to end the day, touched the lowest level in trading since October 18th of 2021.

PFE is now about $20 per share lower than the 2021 high of 61.71 reached on December 20th of 2021 and as you can see on the charts, the long and short moving averages are both pointing down.

PFE Stock today rose by 1.64 percent after close to 52-week low

 

The PFE RSI level is Bearish

The Relative Strength Index, an indicator that can indicate overbought (above 70) and oversold levels (below 30), shows that the current RSI is at a 33.7 score. This is a Bearish reading on the daily time-frame and PFE is just above the oversold level.

PFE Price Trends (Closing Price Changes)

The PFE has slid by -3.89 percent over the past 10 days while seeing a step lower by -8.34 over the past 30 days. The 90-day change is -18.94 while the 180-day return and the 365-day return are -15.83 and 15.37, respectively.

PFE has slid by -3.89 percent over the past 10 days while seeing a step lower by -8.34 over the past 30 days

By InvestMacro.com Get our stock market newsletter for stock rankings, news & updates

NIO Stock declined by -2.28 percent, Oversold RSI – October 11 2022

By InvestMacro.com Get our stock market newsletter for stock rankings, news & updates | #stocks #NIO

NIO Inc. End of Day Update: October 11th 2022

The NIO Inc. (NIO) stock ended the day with a slide of -2.28 percent and closed the day around the 12.83 price level, according to unofficial data at the New York close.

NIO, a Chinese electric car company, opened the day trading at the 13.13 trading level with the high of the day being 13.42 and the low of the day falling to 12.58. The 20-day and 200-day moving averages are both pointing down at this point and the stock is trading at the lowest levels since May 22nd.

NIO Stock declined by -2.28 percent, Oversold RSI

The NIO RSI level is Bearish-Oversold

The Relative Strength Index, an indicator that can indicate overbought (above 70) and oversold levels (below 30), shows that the current RSI is currently at a 27.1 score. This is a Bearish-Oversold reading on the daily time-frame.

NIO Price Trends (Closing Price Changes)

NIO is now down by -25.36 percent over the past 10 days while seeing a fall of -35.23 over the past 30 days. The 90-day change is -31.94 while the 180-day return and the 365-day return are -48.41 and -67.80, respectively.

NIO Price Trends (Closing Price Changes)

By InvestMacro.com – Get our stock market newsletter for stock rankings, news & updates

Wall Street Hemophilia

Source: Michael Ballanger  (10/11/22)

Expert Michael Ballanger of GGM Advisory reviews the current stock market, the outlook for gold, and how he believes everyone should move forward.

Exactly nine months ago this weekend, I sounded the alarm for the pending arrival of a bear market in financial assets when “The First Five Days” of the January Barometer flashed a warning signal by closing lower than the end-of-year number from the prior week.

The Rolling Bear Market

For nearly the next eight months, I watched and read advisors, bloggers, and podcasters all chortle on and on in breathless anticipation of the emergence of the “Fed Pivot” to the extent that every sign of an abatement in the CPI numbers was met with mindless euphoria and wave after wave of buying while Wall Street insiders and corporate executives quietly and without fanfare were selling massive amounts of paper.

The volume and blatancy of insider sales were astonishingly outdone by the retail “buy-the-dipping” that results from the well-crafted Fed “script” that trains the kiddies to expect policy rescue and accompanying deliverance from portfolio purgatory.

Warren Buffett is quoted as saying that maximizing stock market performances involves being “Fearful when others are greedy and greedy when others are fearful.”

I had been holding fast to my strategy of fading every advance while pressing bearish bets while rolling bear market profits into additional (and egregiously large) precious metals holdings, which, up until Wednesday, September 28, 2022, seemed like a pretty good strategy.

However, the landscape all changed when the Bank of England announced it was buying — instead of selling — gilts (10-year U.K. bonds), putting an immediate end to the U.K. version of quantitative tightening and rather than calling it “easing,” they simply called it “temporary” and “emergency” purchases.

What resulted was a 7% rally in the S&P 500 on mammoth volume, and while pundits dismissed it as yet another “bear market rally” that should be sold aggressively, only with the fullness of time will I know without question the veracity of the MACD buy signal shown below,

Call it a “trader’s intuition,” call it a “gut feel,” or call it a “contrarian set-up” I think that the ferocity of retail dumping and shorting is moving to “overblown” status.

I furthermore think that the Twitterverse, with all of the gold bugs delighting in the demise of every sector that was in the limelight since March 2009, remains “interesting.”

Tech, crypto, and social media — all totally trashed in the past year — are now being jettisoned like spent boosters on a NASA launch.

It still astounds me how quickly the darlings of today become the pariahs of tomorrow.

I also sense extreme investor apprehension here due to the month of October, known as the “jinx month” because of crashes in 1929 and 1987, a 554-point swoon in 1997 as well as back-to-back massacres in 1977 and 1979, “Friday the Thirteenth crash in 1989 and finally the subprime meltdown in 2008.

All of these nerve-rattling declines represented the terminal moves in a longer-term trend of lower prices and were followed by extended rallies in 1946, 1957, 1960, 1974, 1987, 1990, 1998, 2001, 2002, and 2011.

Should You Be Cautious?

 

I have countless times written about the difficulties in trying to pick bottoms or tops during the final parabolic “terminal” moves that characterize important turning points.

This is why I usually scale into positions in October because while market trendlines that move from gradual to vertical provide me with a sense of how close the lows are in terms of time, they do not provide me with the same sense as to price.

So if the bottoming process takes three weeks in October, I might be paying US$10 in week one but US$2 in week three, so nibbling away in tranches is a reasonable strategy.

Even if I get caught in a 1987-style crash, some of the entry points are going to be ridiculously lower than where they are once panic subsides (which it always does), and bargain hunters arrive in droves.

Make no mistake; there are dozens of reasons to be cautious but based upon everything I have learned since 1974, the first time I picked up a Wall St. Journal (understanding nothing), there are an even greater number of reasons to be optimistic as you have read in the above paragraphs.

I have told everyone to fade the markets until the Fed openly admits to a policy reversion from the current “hostile” to a more “friendly” stance.

Even a “neutral” stance would allow for a sharp relief rally lasting several months and classified as a tradable rally.

Gold

Gold is acting far better here in October than it was in September (as is silver), and while I am long both, I am modestly ahead on silver and moronically underwater on gold.

That said, I believe that once this difficult month of October is behind us, I see a rally unfolding in all risk assets, and despite the fact that the only asset class that is devoid of anything resembling counterparty risk is the physical precious metals sector, the money managers of the world choose to lump the PM’s together with growth stocks, crypto, and high-tech zombies under the label of “risk assets.”

Alas, I am neither able nor willing to debate it in the world of social media hatemongers because it is pointless. It is like the debate over precious metals manipulation; it does not matter who wins the debate when the control of price is in the hands of a few government-sanctioned bullion banks.

I continue to hold that new purchases should be in physical gold and/or silver so as to avoid inclusion in the “risky stocks” all-encompassing drawdown potential where it matters not that you are a gold and silver producer, explorer, or developer when the margin calls arrive, you get trashed.

Mind you, in 2008 and 2020, they took cash prices lower as well, which contrasted 1987 when the cash market for gold went from US$425 to US$505 in a week, while the TSE Gold and Silver Index containing all the big gold miners crashed from over 10,000 to less than half of that.

Fear and Greed

Warren Buffett is quoted as saying that maximizing stock market performances involves being “Fearful when others are greedy and greedy when others are fearful.”

I like to add the adjective “irrationally” as in “irrationally fearful” with yet another quote in mind, and that one being from the mouth of John Maynard Keynes, who reminded us that “Stocks can remain irrational longer than we can remain solvent.”

Do you wait for the result and then move?  Do as you must, but I do not want to be short in November.

Sometimes markets can remain “irrationally fearful” much longer than I might have reasonably expected, and that is where I try to discipline myself to focus on position size.

As an example, I might be totally convinced that the S&P is going to close out the year back above 4,000 but rather than going “all-in,” I use call options with a finite dollar amount of risk rather than a fully-leveraged portfolio.

This is because if I am wrong, I will still have an ample cash position with which to react, especially if things take longer or not at all, which does happen.

There is no doubt that there is a lot of blood flowing in the streets right now, and with the fear-greed gauges at levels last seen in April 2020, December 2018, March 2009, and October 2008, I believe it is time to reduce my bearish exposures and slowly shift to a conservatively-bullish stance.

I am loaded with junior copper/gold /silver /uranium developers but have no positions in the broad market components that will have the highest “beta” in the advent of a “risk-on” shift brought about by the specter of a bullish policy reversal.

Wealth managers across the planet are all hemorrhaging, creating this torrent of Main Street gore to the extent that some very large pools of investment capital are ready to pounce.

Do not think for a minute that the mid-term U.S. elections are a factor in keeping pressure on the markets; once the Democrats are ceremoniously swept out of the House and Senate, watch for a serious rebound.

Do you wait for the result and then move?  Do as you must, but I do not want to be short in November.

Think “risk-on” because we have had nine months of “risk-off,” and the blogosphere is short up to the teeth. . .

Michael Ballanger Disclaimer:

This letter makes no guarantee or warranty on the accuracy or completeness of the data provided. Nothing contained herein is intended or shall be deemed to be investment advice, implied or otherwise. This letter represents my views and replicates trades that I am making but nothing more than that. Always consult your registered advisor to assist you with your investments. I accept no liability for any loss arising from the use of the data contained on this letter. Options and junior mining stocks contain a high level of risk that may result in the loss of part or all invested capital and therefore are suitable for experienced and professional investors and traders only. One should be familiar with the risks involved in junior mining and options trading and we recommend consulting a financial adviser if you feel you do not understand the risks involved.

Disclosures:

1) Statements and opinions expressed are the opinions of Michael Ballanger and not of Streetwise Reports or its officers. Michael Ballanger is wholly responsible for the validity of the statements. Streetwise Reports was not involved in any aspect of the article preparation. Michael Ballanger was not paid by Streetwise Reports LLC for this article. Streetwise Reports was not paid by the author to publish or syndicate this article.

2) This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.

3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.

4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.

5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the decision to publish an article until three business days after the publication of the article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Silver X Mining Corp., a company mentioned in this article.

Chen Reveals His Picks for Last Quarter

Source: Streetwise Reports  (10/11/22)

Asset manager Chen Lin’s picks for the home stretch of 2022 include several biotechs and some precious metals companies.

Asset manager Chen Lin’s picks for 2022’s last quarter include a whole stable of biotechs with some precious metals thrown in.

He cashed out of one position and doubled down on some others.

According to Zacks research, the biomedical and genetics industry has underperformed the S&P 500 Index and the medical sector so far in 2022, having declined 28.9% compared to 25% for both the medical sector and S&P.

But there is hope on the horizon. The sector carries a current Zacks industry rank of 77, which puts it in the top 31% of more than 251 industries Zacks tracks.

Biotech “bottomed around mid-year,” Chen said. “Now it is starting to rebound. I had a good year in biotech. I see continuing rebounds of my biotechs in the coming years.”

Tricida Inc.

Tricida, Inc. (TCDA:NASDAQ) is developing Veverimer, which is designed to treat metabolic acidosis in patients with chronic kidney disease. It’s a return from Q3 on Chen’s list.

The U.S. Food and Drug Administration (FDA) did not approve the drug in 2020, but the company is awaiting the outcome of a new trial which will be “the most important data readout in its history,” Chen said.

“The chance of positive data (in the trial) is extremely high, in my opinion,” Chen said. “With the positive data, TCDA can file for approval next year. The stock has at least a 10-fold upside after approval.”

Top shareholders in the company include OrbiMed Advisors LLC at 18.47%, VR Adivser LLC at 17.14%, Sibling Capital Ventures LLC at 11.54%, and Steven A. Cohen at 5.9%, according to Reuters.

Tricida’s market cap is US$659.68 million, with 55.7 million shares outstanding, 51 million of them free-floating. It trades in a 52-week range of US$13.85 and US$4.10.

Amyris Inc.

Another returning pick for Chen is Amyris, Inc. (AMRS:NASDAQ), asynthetic biotech company that “programs” cells to create sustainable ingredients.

The company has begun production at its new precision sugar fermentation plant in Brazil.

The plant consists of five precision fermentation “mini-factories” that can produce 13 of Amyris’ molecules, which are used in everything from health and beauty products to flavors and fragrances.

Amyris is a frontrunner for US$1 billion the U.S. Department of Defense will be investing in the bioindustrial domestic manufacturing infrastructure over the next five years.

It’s part of the US$2 billion the U.S. government plans to spend to boost biomanufacturing under an executive order announced last month.

“The decision could come in the next couple of months,” Chen said. “In addition, AMRS’ own lines of business are on fire . . . 2023 should be the year they turn cash positive.”

Amyris’ top shareholders include Foris Ventures LLC at 22.86%, Farallon Capital Management LLC at 6.56%, The Vanguard Group Inc. at 5.9%, Koninklijke DSM NV at 5.16%, and BlackRock Institutional Trust Co. N.A. who holds 3.68%.

Its market cap is US$846.26 million, and it has 323.4 million shares outstanding, 227.6 million of them free-floating. It trades in a 52-week range of US$15.12 and US$1.47.

Synaptogenix Inc.

A new pick for Chen is Synaptogenix Inc. (SNPX:NASDAQ), a biopharmaceutical company developing Bryostatin-1 for Alzheimer’s disease.

The company is just about to report data from its Phase 2 trials, which were partially funded by the National Institutes of Health.

“This trial, if successful, would open up a brand new approach to reverse Alzheimer’s,” Chen said.

The stock is a “very high-risk play,” he said, but he owns “a small position here as a lottery ticket.”

Top shareholders include Intracoastal Capital LLC at 7.17%, Alpha Capital Aktiengesellschaft at 4.41%, George Weaver Haywood at 3.44%, The Vanguard Group at 3.17%, and Ikarian Capital LLC at 1.77%.

The company’s market cap is US$48.23 million, with 6.84 million shares outstanding, 5.76 million of them free-floating. It trades in a 52-week range of US$14.50 and US$3.79.

GoGold Resources Inc.

GoGold Resources Inc. (GGD:TSX) is a Nova Scotia-based silver and gold producer operating in Mexico. It operates the Parral Tailings mine in the state of Chihuahua and has the Los Ricos South and Los Ricos North exploration projects in the state of Jalisco.

Chen said he took advantage of a big dip in its price recently to load up on his position.

“GGD has . . . cash, a silver-producing mine, and a new discovery,” he said. “It looks very undervalued.”

Ownership includes Bradley H. Langille with 5.22%, Van Eck Associates Corp. with 4.41%, Franklin Advisers Inc. with 4.35%, Sprott Asset Management LP with 3.1%, and Mirae Asset Global Investments (USA) LLC with 2.7%.

It has a market cap of CA$461.3 million, with 295.6 million shares outstanding, 275.2 million of them free-floating. It trades in a 52-week range of CA$3.79 and CA$1.37.

He said he also likes other silver producers such as Silver X Mining Corp. (AGX:TSX.V).

Chen Lin strongly recommends that investors load up on silver and silver miners for the coming tax loss selling season.

Axsome Therapeutics Inc.

Last quarter, Chen doubled down his top pick from Q2, Axsom Therapeutics Inc. (AXSM:NASDAQ), a biopharmaceutical company that focuses on therapies for central nervous system conditions.

The company had been waiting on decisions from the FDA on drug candidates for major depressive disorder and migraine.

The FDA has approved the major depressive disorder drug, Auvelity, and Chen said he sold out his position when it was at about US$70.

Axsome’s top shareholders include Antecip Capital LLC at 18.22%, The Vanguard Group Inc. at 6.95%, BlackRock Institutional Trust Co. N.A. at 4.99%, RTW Investments LP at 4.02%, and PFM Health Sciences LP at 3.38%.

It has a market cap of US$1.95 billion with 40.3 million shares outstanding, 32.3 million of them free-floating. It trades in a 52-week range of US$71.98 and US$20.63.

Disclosures:

1) Steve Sobek wrote this article for Streetwise Reports LLC. He or members of his household own securities of the following companies mentioned in the article: None. He or members of his household are paid by the following companies mentioned in this article: None.

2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.

3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.

4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.

5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the decision to publish an article until three business days after the publication of the article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Silver X Mining Corp., a company mentioned in this article.

Nobel economics prize: insights into financial contagion changed how central banks react during a crisis

By Elena Carletti, Bocconi University 

This year’s Nobel prize in economics, known as the Sveriges Riksbank Prize in Economic Sciences, has gone to Douglas Diamond, Philip Dybvig and former Federal Reserve Chair Ben Bernanke for their work on banks and how they relate to financial crises.

To explain the work and why it matters, we talked to Elena Carletti, a Professor of Finance at Bocconi University in Milan.

Why have Diamond, Bernanke and Dybvig been awarded the prize?

The works by Diamond and Dybvig essentially explained why banks exist and the role they play in the economy by channelling savings from individuals into productive investments. Essentially, banks play two roles. On the one hand, they monitor borrowers within the economy. On the other, they provide liquidity to individuals, who don’t know what they will need to buy in future, and this can make them averse to depositing money in case it’s not available when they need it. Banks smooth out this aversion by providing us with the assurance that we will be able to take out our money when it’s required.

The problem is that by providing this assurance, banks are also vulnerable to crises even at times when their finances are healthy. This occurs when individual depositors worry that many other depositors are removing their money from the bank. This then gives them an incentive to remove money themselves, which can lead to a panic that causes a bank run.

Ben Bernanke fed into this by looking at bank behaviour during the great depression of the 1930s, and showed that bank runs during the depression was the decisive factor in making the crisis longer and deeper than it otherwise would have been.

The observations behind the Nobel win seem fairly straightforward compared to previous years. Why are they so important?

It’s the idea that banks that are otherwise financially sound can nevertheless be vulnerable because of panicking depositors. Or, in cases such as during the global financial crisis of 2007-09, it can be a combination of the two, where there is a problem with a bank’s fundamentals but it is exacerbated by panic.

Having recognised the intrinsic vulnerability of healthy banks, it was then possible to start thinking about policies to alleviate that risk, such as depositor insurance and reassuring everyone that the central bank will step in as the lender of last resort.

In a bank run caused by liquidity (panic) rather than insolvency, an announcement from the government or central bank is likely to be enough to solve the problem on its own – often without the need for any deposit insurance even being paid out. On the other hand, in a banking crisis caused by insolvency, that’s when you need to pump in money to rescue the institution.

What was the consensus about bank runs before Diamond and Dybvig began publishing their work?

There had been a lot of bank runs in the past and it was understood that financial crises were linked to them – particularly before the US Federal Reserve was founded in 1913. It was understood that bank runs made financial crises longer by exacerbating them. But the mechanism causing the bank runs wasn’t well understood.

How easy is it to tell what kind of bank run you are dealing with?

It’s not always easy. For example, in 2008 in Ireland it was thought to be a classic example of bank runs caused by liquidity fears. The state stepped up to give a blanket guarantee to creditors, but it then became apparent that the banks were really insolvent and the government had to inject enormous amounts of money into them, which led to a sovereign debt crisis.

Speaking of sovereign debt crises, the work by Diamond and Dybvig also underpins the literature on financial contagion, which is based on a 2000 paper by Franklin Allen and Douglas Gale. I worked with Allen and Gale for many years, and all our papers have been based on the work of Diamond, and Diamond and Dybvig.

In a similar way to how state reassurances can defuse a bank run caused by liquidity problems, we saw how the then European Central Bank President Mario Draghi was able to defuse the run on government bonds in the eurozone crisis in 2011 by saying that the bank would do “whatever it takes” to preserve the euro.

The prize announcement has attracted plenty of people on social media saying we shouldn’t be celebrating Bernanke when he was so involved in the quantitative easing (QE) that has helped to cause today’s global financial problems – what’s your view?

I would say that without QE our problems would today be much worse, but also that the prize recognises his achievements as an academic and not as chair of the Fed. Also, Bernanke was only one of the numerous central bankers who resorted to QE after 2008.

And it is not only the central bank actions that make banks stable. It’s also worth pointing out that the changes to the rules around the amount of capital that banks have to hold after 2008 have made the financial system much better protected against bank runs than it was beforehand.

Should such rules have been introduced when the academics first explained the risks around bank runs and contagion?

The literature had certainly hinted at these risks, but regulation-wise, we had to wait until after the global financial crisis to see reforms such as macro-prudential regulation and more stringent micro-prudential regulation. This shows that regulators were underestimating the risk of financial crises, perhaps also pushed by the banking lobbies that had been traditionally very powerful and managed to convince regulators that risks were well managed.

If retail banks become less important in future because of blockchain technology or central bank digital currencies, do you think the threat of financial panic will reduce?

If we are heading for a situation where depositors put their money into central banks rather than retail banks, that would diminish the role of retail banking, but I think we are far from that. Central bank digital currencies can be designed in such a way that retail banks are still necessary. But either way, the insights from Diamond and Dybvig about liquidity panics are still relevant because they apply to any context where coordination failures among investors are important, such as sovereign debt crises, currency attacks and so on.The Conversation

About the Author:

Elena Carletti, Professor of Finance, Bocconi University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Forex Technical Analysis & Forecast 11.10.2022

Article By RoboForex.com

EURUSD, “Euro vs US Dollar”

After completing the descending wave at 0.9681 along with the correction up to 0.9744, EURUSD has broken the low of this wave; right now, it is still falling towards 0.9660 and may later form a new consolidation range around the latter level. After that, the instrument may break the range to the downside and resume falling with the target at 0.9580, or even extend this structure sown to 0.9500.

EURUSD
Risk Warning: the result of previous trading operations do not guarantee the same results in the future

GBPUSD, “Great Britain Pound vs US Dollar”

GBPUSD is still consolidating around 1.1068. Possibly, today the pair may break the range to the downside and resume falling towards 1.0919. After that, the instrument may start a new correction to test to 1.1000 from below and then resume trading downwards with the target at 1.0633.

GBPUSD
Risk Warning: the result of previous trading operations do not guarantee the same results in the future

USDJPY, “US Dollar vs Japanese Yen”

After rebounding from 145.60, USDJPY is growing towards 145.98. Later, the market may start another correction to reach 144.77 and then form one more ascending wave with the target at 146.46.

USDJPY
Risk Warning: the result of previous trading operations do not guarantee the same results in the future

USDCHF, “US Dollar vs Swiss Franc”

After finishing the ascending wave at 1.0020, USDCHF is expected to form a new consolidation range there. Later, the market may break the range to the upside to reach 1.0073 and then resume trading downwards with the target at 0.9900.

USDCHF
Risk Warning: the result of previous trading operations do not guarantee the same results in the future

AUDUSD, “Australian Dollar vs US Dollar”

Having broken the consolidation range to the downside, AUDUSD is still falling towards 0.6222. After that, the instrument may correct up to 0.6323 and then start a new decline with the target at 0.6200.

AUDUSD
Risk Warning: the result of previous trading operations do not guarantee the same results in the future

BRENT

Brent is correcting down to 94.80. After that, the instrument may resume trading upwards with the target at 100.80, or even extend this structure up to 103.50.

BRENT
Risk Warning: the result of previous trading operations do not guarantee the same results in the future

XAUUSD, “Gold vs US Dollar”

After completing the descending wave at 1661.20, Gold is forming a new consolidation range there. If later the price breaks this range to the upside, the market may correct up to 1679.00; if to the downside – resume falling with the target at 1629.40.

GOLD
Risk Warning: the result of previous trading operations do not guarantee the same results in the future

S&P 500

The S&P index is consolidating below 3624.0. Possibly, the asset may resume trading downwards to reach 3500.0. Later, the market may correct up to 362.0 and then continue trading downwards with the target at 3444.0.

S&P 500

Article By RoboForex.com

Attention!
Forecasts presented in this section only reflect the author’s private opinion and should not be considered as guidance for trading. RoboForex LP bears no responsibility for trading results based on trading recommendations described in these analytical reviews.

Murrey Math Lines 11.10.2022 (AUDUSD, NZDUSD)

Article By RoboForex.com

AUDUSD, “Australian Dollar vs US Dollar”

As we can see in the H4 chart, AUDUSD is trading below the 200-day Moving Average to indicate a possible descending tendency. The Relative Strength Index is moving within the ”oversold area”. In this case, the pair is expected to test 4/8 (0.6347), break it, and then continue growing towards the resistance at 5/8 (0.6469). However, this scenario may be cancelled if the price breaks the support at 3/8 (0.6225) to the downside. After that, the instrument may move downwards to reach 2/8 (0.6103).

AUDUSDH4
Risk Warning: the result of previous trading operations do not guarantee the same results in the future

In the M15 chart, the pair may break the upside line of the VoltyChannel indicator and, as a result, continue its growth.

AUDUSD_M15
Risk Warning: the result of previous trading operations do not guarantee the same results in the future

NZDUSD, “New Zealand Dollar vs US Dollar”

As we can see in the H4 chart, NZDUSD is also trading below the 200-day Moving Average, thus indicating a descending tendency. The Relative Strength Index is approaching the “oversold area”. In this case, the price is expected to test 1/8 (0.5493), rebound from it, and then resume moving upwards to reach the resistance at 3/8 (0.5737). However, this scenario may no longer be valid if the price breaks the support at 1/8 (0.5493) to the downside. After that, the instrument may continue falling towards 0/8 (0.5371).

NZDUSD_H4
Risk Warning: the result of previous trading operations do not guarantee the same results in the future

In the M15 chart, the pair may break the upside line of the VoltyChannel indicator and, as a result, continue moving upwards to reach 3/8 (0.5737).

NZDUSD_M15

Article By RoboForex.com

Attention!
Forecasts presented in this section only reflect the author’s private opinion and should not be considered as guidance for trading. RoboForex LP bears no responsibility for trading results based on trading recommendations described in these analytical reviews.